Analyst firms · DZ Bank · LLY
DZ Bank LLY price target and rating history
Eli Lilly and Company (LLY) · Health Care
DZ Bank rates Eli Lilly and Company (LLY) Hold with a $820 price target, as of its latest action on Feb 21, 2024. It has published 3 rating actions on LLY since August 2021, including 2 upgrades and 1 downgrade. Across 8 firms with a LLY price target in the last 12 months, the median target is $1,250.
- Current rating
- Hold
- Price target
- $820
- Median target, all firms
- $1,250
- Actions on LLY
- 3
DZ Bank price target on LLY
Every DZ Bank rating on LLY
- Feb 21, 2024
- Jan 21, 2022
- Aug 5, 2021
How other firms rate LLY
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Berenberg | Buy | $1,400 | Sep 15, 2026 |
| HSBC | Reduce | $850 | Mar 17, 2026 |
| RBC Capital Markets | Outperform | $1,250 | Feb 25, 2026 |
| Barclays | Overweight | $1,350 | Feb 20, 2026 |
| UBS | Buy | $1,250 | Jan 7, 2026 |
| Daiwa | Buy | $1,230 | Dec 16, 2025 |
| Goldman Sachs | Buy | $1,145 | Dec 15, 2025 |
| BofA Securities | Buy | $1,268 | Dec 15, 2025 |
Questions about DZ Bank and LLY
- What is DZ Bank's price target for LLY?
- DZ Bank's latest stated price target for Eli Lilly and Company (LLY) is $820, from its action on Feb 21, 2024.
- What is DZ Bank's rating on LLY?
- DZ Bank rates LLY Hold, a neutral rating, as of Feb 21, 2024.
- When did DZ Bank last change its view on LLY?
- On Feb 21, 2024, DZ Bank downgrades to Hold from Buy, price target $820.
- How does DZ Bank's LLY target compare with other analysts?
- Across 8 firms with a LLY price target in the last 12 months, the median target is $1,250.
More LLY rating histories
- Berenberg4
- HSBC4
- Barclays3
- UBS4
- Daiwa4
- BofA Securities4
- Leerink Partners3
- BMO Capital Markets3
- Citigroup3
- Morgan Stanley6
- Wells Fargo3
All DZ Bank ratingsLLY news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.